Form 8-K - Current report:
SEC Accession No. 0001214659-17-005307
Filing Date
2017-08-25
Accepted
2017-08-25 16:30:23
Documents
5
Period of Report
2017-08-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 j8241708k.htm 8-K 34173
2 EXHIBIT 4.1 ex4_1.htm EX-4.1 175644
3 EXHIBIT 10.1 ex10_1.htm EX-10.1 621558
4 EXHIBIT 99.1 ex99_1.htm EX-99.1 11763
5 humanigen_logo.jpg GRAPHIC 19432
  Complete submission text file 0001214659-17-005307.txt   871369
Mailing Address 1000 MARINA BOULEVARD SUITE 250 BRISBANE CA 94005-1878
Business Address 1000 MARINA BOULEVARD SUITE 250 BRISBANE CA 94005-1878 650.243.3100
HUMANIGEN, INC (Filer) CIK: 0001293310 (see all company filings)

EIN.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35798 | Film No.: 171052334
SIC: 2834 Pharmaceutical Preparations